Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia.

Primary adrenal insufficiency (PAI) is characterized by the inability of the adrenal cortex to produce sufficient amounts of glucocorticoids and/or mineralocorticoids. Addison's disease (AD) and congenital adrenal hyperplasia (CAH) are the most frequent disorders in adults and children, respectively. Despite the diagnostic advances and the availability of glucocorticoid and mineralocorticoid replacements, adrenal crisis (AC) is still a potentially lethal condition contributing to the increased mortality, not only during the first year of life, but also throughout life. Failure in increasing glucocorticoid doses during acute stress, when greater amounts of glucocorticoids are required, can lead to AC and an increase morbimortality rate of PAI. Considering a mortality rate of 0.5 per 100 patient years, up to 1,500 deaths from AC are expected in Brazil in the coming decade, which represents an alarming situation. The major clinical features are hypotension and volume depletion. Nonspecific symptoms such as fatigue, lack of energy, anorexia, nausea, vomiting, and abdominal pain are common. The main precipitating factors are gastrointestinal diseases, other infectious disease, stressful events (e.g., major pain, surgery, strenuous physical activity, heat, and pregnancy), and withdrawal of glucocorticoid therapy. Suspected AC requires immediate therapeutic action with intravenous (iv) hydrocortisone, fluid infusion, monitoring support, and antibiotics if necessary. AC is best prevented through patient education, precocious identification and by adjusting the glucocorticoid dosage in stressor situations. The emergency card, warning about acute glucocorticoid replacement, has high value in reducing the morbidity and mortality of AC.

[1]  H. Falhammar,et al.  Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis , 2021, Endocrine.

[2]  D. Torpy,et al.  Prehospital Management of Acute Addison Disease: Audit of Patients Attending a Referral Hospital in a Regional Area , 2019, Journal of the Endocrine Society.

[3]  Sandra P. Spencer,et al.  Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings , 2019, Journal of Investigative Medicine.

[4]  Zhichun Feng,et al.  Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[5]  C. Currie,et al.  Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia. , 2018, European journal of endocrinology.

[6]  Y. Balakrishna,et al.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency in South Africa. , 2018, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[7]  J. Bertherat,et al.  Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality. , 2017, Annales d'endocrinologie.

[8]  P. Chanson,et al.  Group 5: Acute adrenal insufficiency in adults and pediatric patients. , 2017, Annales d'endocrinologie.

[9]  C. D. de Korte,et al.  Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency , 2017, Journal of pediatric endocrinology & metabolism : JPEM.

[10]  M. Keil,et al.  The Key to Adrenal Insufficiency Education: Repetition, Repetition, Repetition. , 2017, Pediatric Endocrinology Reviews: diabetes, nutrition, metabolism.

[11]  B. Mendonca,et al.  Neonatal 17‐hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening , 2017, Clinical endocrinology.

[12]  P. Zelissen,et al.  Adrenal Crisis: Still a Deadly Event in the 21st Century. , 2016, The American journal of medicine.

[13]  Stefan R Bornstein,et al.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[14]  W. H. Hannon,et al.  Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states. , 2015, Molecular genetics and metabolism.

[15]  S. Hahner,et al.  Diagnosis and management of adrenal insufficiency. , 2015, The lancet. Diabetes & endocrinology.

[16]  B. Allolio Extensive expertise in endocrinology. Adrenal crisis. , 2015, European journal of endocrinology.

[17]  F. Beuschlein,et al.  High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. , 2015, The Journal of clinical endocrinology and metabolism.

[18]  H. Falhammar,et al.  Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2014, The Journal of clinical endocrinology and metabolism.

[19]  K. Badenhoop,et al.  Consensus statement on the diagnosis, treatment and follow‐up of patients with primary adrenal insufficiency , 2014, Journal of internal medicine.

[20]  A. Grossman,et al.  THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe , 2013, European journal of endocrinology.

[21]  P. White,et al.  Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Deficiency: From Birth to Adulthood , 2012, Seminars in Reproductive Medicine.

[22]  F. Beuschlein,et al.  Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. , 2012, European journal of endocrinology.

[23]  S. Hahner,et al.  Addisonian crisis in a young man with atypical anorexia nervosa , 2011, Nature Reviews Endocrinology.

[24]  E. Hahn,et al.  Cortisone replacement therapy in endocrine disorders - quality of self-care. , 2010, Journal of evaluation in clinical practice.

[25]  M. Fassnacht,et al.  Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. , 2010, European journal of endocrinology.

[26]  W. Arlt,et al.  Adrenal crisis in treated Addison's disease: a predictable but under-managed event. , 2010, European journal of endocrinology.

[27]  S. Suvarna Fatal Addison’s disease in a teenager , 2009, Journal of Clinical Pathology.

[28]  J. Svartberg,et al.  Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. , 2008, European journal of endocrinology.

[29]  A. Hermus,et al.  [Addisonian crisis in patients with known adrenal insufficiency: the importance of early intervention]. , 2008, Nederlands tijdschrift voor geneeskunde.

[30]  S. Bird Failure to diagnose: Addison disease. , 2007, Australian family physician.

[31]  D. Shulman,et al.  Adrenal Insufficiency: Still a Cause of Morbidity and Death in Childhood , 2007, Pediatrics.

[32]  G. Johannsson,et al.  Premature mortality in patients with Addison's disease: a population-based study. , 2006, The Journal of clinical endocrinology and metabolism.

[33]  D. Wysowski,et al.  Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. , 2004, The Journal of pediatrics.

[34]  B. Therrell Newborn screening for congenital adrenal hyperplasia. , 2001, Endocrinology and metabolism clinics of North America.

[35]  R. Sapolsky,et al.  How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. , 2000, Endocrine reviews.

[36]  J. Fischer,et al.  Adrenal crisis presenting as hypoglycemic coma , 2000, Intensive Care Medicine.

[37]  C. Longui,et al.  Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. , 1998, The Journal of clinical endocrinology and metabolism.

[38]  D. Dunger,et al.  Mortality in patients with congenital adrenal hyperplasia: a cohort study. , 1998, The Journal of pediatrics.

[39]  B. Chernow,et al.  Perioperative Glucocorticoid Coverage A Reassessment 42 Years After Emergence of a Problem , 1994, Annals of surgery.

[40]  C. Dinarello,et al.  Interleukin‐1 and Glucocorticoid Hormones Integrate an Immunoregulatory Feedback Circuit a , 1987, Annals of the New York Academy of Sciences.

[41]  N. Molander Sudden natural death in later childhood and adolescence. , 1982, Archives of disease in childhood.

[42]  K. Iwai [Adrenal crisis]. , 1970, Nihon rinsho. Japanese journal of clinical medicine.

[43]  J. N. Morris,et al.  Epidemiological and clinical picture of Addison's disease. , 1968, Lancet.

[44]  D. Dunlop EIGHTY-SIX CASES OF ADDISON'S DISEASE. , 1963, British medical journal.